One dead after legionnaires' outbreak
NSW Health said 12 people who spent time in the city and surrounding suburbs between March and April had contracted the deadly disease.
'Sadly, one of the people who contracted the disease passed away in hospital last week,' a NSW Health spokesman said on Wednesday.
Authorities tested more than 165 cooling towers in the city and detected legionella bacteria in one.
The cooling tower is being decontaminated and further tests are being conducted to determine if it was the source of the outbreak.
Anyone who was in the Sydney CBD and surrounding suburbs between March and April is urged to be aware of symptoms including fever, chills, coughing and shortness of breath.
Symptoms can develop up to 10 days after exposure and anyone who experiences symptoms should see their doctor.
South Eastern Sydney Local Heath District Public Health Unit Director Vicky Sheppeard said 11 people with the disease had been hospitalised and one person received care out of hospital.
'Legionnaires' disease is caused by infection with legionella bacteria,' Dr Sheppeard said.
'Outbreaks sometimes occur when bacteria from environmental sources such as cooling towers atop large buildings become contaminated. It is not spread from person to person.
'NSW Health continues to work closely with the City of Sydney to identify, inspect and sample any cooling towers in the CBD potentially implicated in the outbreak.
'Most building owners have responded quickly to ensure that their cooling towers are operated and maintained in compliance with the NSW Public Health Regulation 2022.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
3 hours ago
- Fox News
At-home test works like coffee rings to spot serious illness faster
Have you ever noticed how a spilled cup of coffee leaves behind a telltale brown ring? While those stains might be annoying, the science behind them, known as the coffee ring effect, has sparked innovations in health technology. UC Berkeley researchers recently turned this everyday phenomenon into a breakthrough medical test, making rapid and reliable disease detection as easy as brewing your morning coffee. Curious how a simple coffee stain could inspire cutting-edge diagnostics and revolutionize at-home testing? Let's look at how a forgotten mug on your desk might just save lives. Ever wondered why spilled coffee, wine or tea dries in a ring rather than evenly? This common pattern is known as the "coffee ring effect." The phenomenon occurs because of the liquid's surface tension. As the drop begins to dry, water at the edges evaporates more quickly since that area is thinner. To keep up, liquid from the center flows outward, carrying tiny particles with it. Once the drop is completely dry, these particles settle along the edge, creating the signature ring stain you see on tables and countertops every day. Surprisingly, that annoying coffee ring on your table has inspired a major breakthrough in medical technology. Researchers at UC Berkeley transformed this everyday nuisance into a powerful new at-home diagnostic test. This innovative test can identify diseases like COVID-19, prostate cancer and sepsis with remarkable accuracy. In fact, it is up to 100 times more sensitive than many current rapid tests. Even better, it delivers results in just twelve minutes, depending on the test. The idea began with Kamyar Behrouzi, a former Ph.D. student at UC Berkeley. While developing a COVID-19 biosensor in 2020, he noticed that virus particles, much like coffee particles, tend to gather at the edge of a droplet. By using this natural effect, the researchers designed a test that captures and concentrates disease markers, making detection much easier. Thanks to this stain-inspired science, fast and reliable testing is now possible right at home. So, how does this innovative test actually work? First, you place a small sample from your nose or cheek onto a special membrane. As the sample dries, disease proteins concentrate at the edges to form a visible ring. Next, you add a second droplet containing light-reactive particles. If certain disease biomarkers are present, these nanoparticles light up when exposed to light. You can see positive results with the naked eye in some cases, or verify them more accurately using a special AI-powered smartphone app. This rapid test does more than detect COVID-19. It can also identify early signs of sepsis, a life-threatening infection that needs quick treatment. To make home testing accessible, the UC Berkeley team even created a 3D-printed prototype for easy use on your kitchen counter. According to professor Liwei Lin, this innovative approach could transform regular health screening, with no lab visit required. This coffee ring-inspired test brings hospital-level disease detection right to your home. With results ready in under twelve minutes, you can quickly check for diseases like COVID-19 and even early signs of sepsis. You no longer need to schedule lab visits or wait days for results. Instead, you can take charge of your health from the comfort of your kitchen, using a simple, affordable tool that could catch problems early and help keep your family safe. As technology like this becomes widely available, routine screening could become as easy as making your morning coffee. It's incredible how a common coffee stain inspired a breakthrough in medical testing. Science proves that even life's little messes can spark big innovations. With these advances, you can look forward to faster, easier health checks at home and maybe appreciate your next coffee spill just a little more. Would you trust a coffee stain to help catch disease early? Let us know by writing us at Sign up for my FREE CyberGuy ReportGet my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you'll get instant access to my Ultimate Scam Survival Guide - free when you join my Copyright 2025 All rights reserved.
Associated Press
4 hours ago
- Associated Press
From Happiest Nation to Healthiest World: Is Agora the Next Unicorn
Female-led startup introduces Build Your Own Doc, turning preventive wellness into a data-driven gamified experience HELSINKI, FI / ACCESS Newswire / July 23, 2025 / Finnish-Australian health technology company Agora, founded by Elizabeth Angel and Dr Olivia Lesslar, has officially launched Build Your Own Doc, a new platform feature that creates personalized AI-driven wellness solutions. The tool can integrate more than one billion biomarkers and over five thousand years of ancient wisdom. Additionally, it draws on two hundred million research papers to create bespoke programs in response to a user's labs and wearables. Agora aims to make proactive wellness more accessible through evidence-based guidance. Elizabeth Angel, CEO of Agora, leads launch of AI wellness platform Build Your Own Doc. 'Wellness is the next human right,' said Angel, Agora's chief executive. 'Agora is not merely software. It is a cultural movement designed to make thriving normal.' With global wellness spending projected to rise from 6.3 trillion to more than 9 trillion US dollars by 2028, the company sees growing demand for preventive tools. Research suggests stress may contribute to 90 percent of illness. Agora addresses this challenge by offering proactive insights for leading causes of chronic disease including heart conditions, cancer, stroke, and Alzheimer's. Agora's leadership reflects a wide range of experience. Angel has worked in humanitarian aid, defense innovation, and applied science. Dr Lesslar, trained in psychoneuroimmunology, brings clinical depth. The idea for the platform was first developed in a Finnish forest, where the team envisioned a technology that blends nature, tradition, and modern science to support healthier habits. The company emphasizes data privacy and user empowerment. Agora's zero-trust architecture ensures personal health data remains under individual control. Users can opt to license anonymized data for research, receive incentives for meeting wellness milestones, or access insurer discounts. 'Health data is the battleground of trust,' Angel said. 'Agora ensures users remain the primary beneficiaries of their own information.' Agora logo The platform's gamified health adventures include sleep tracking, nutrition challenges, and reflective activities. Pilot users reported a 42 percent increase in healthy behavior adherence compared to traditional apps. Other features include community groups and fun support groups focused on healthspan vs lifespan and emotional well-being. Unlike single-focus platforms, Agora combines biometric feedback from both the body and brain, lab results, the user's own assessments and contextual inputs to generate cohesive recommendations through an interactive experience. The goal is to unify fragmented wellness tools into a single, user-friendly system. Since March 2023, Agora has launched across six continents, working with veterans, nonprofits, and educational groups. The platform's free Library tier includes neuroscience-informed music by Ravyn Lyte, an AI-generated artist designed to support calm and focus. Agora's enterprise pilots are scheduled to begin in Q3 with several Fortune 500 companies, targeting workplace burnout and stress. Additional testing with military teams includes gamified adventures for consolidating resilience. Research is also underway to evaluate its benefits for frontline workers and trauma response. Stress-related productivity losses cost the global economy nearly one trillion US dollars each year. Companies face an additional 18 percent payroll impact due to employee disengagement. Agora's approach offers a scalable method to improve well-being and quality of life. Analysts highlight the platform's low acquisition cost and strong alignment with demand for alternative wellness solutions. Angel emphasized mission over market value. 'The goal is to help billions thrive. Subscription revenue from enterprises helps us offer access to the people who need it most.' Agora continues to expand its partnerships across public and private sectors. If adoption accelerates, Finland may soon be known not only as the world's happiest nation but also as a leader in preventive health innovation. About Agora Agora is a global innovation company that accelerates groundbreaking solutions by cross-pollinating emerging technologies across traditionally siloed industries, from health to defense to music and everything in between. Fueling a worldwide movement that spans six continents, Agora creatively bridges the gap between innovation and the critical resources needed, such as funding and distribution channels, all with the aim of uplifting humanity. Media Contact Amy Wellington Agora [email protected] Explore Agora Registration is now open at SOURCE: Agora press release
Yahoo
10 hours ago
- Yahoo
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference
SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will be participating in the BTIG Virtual Biotechnology Conference being held July 29-30, 2025. To schedule a one-on-one meeting with management, please reach out to your BTIG representative. About Belite BioBelite Bio is a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, such as Stargardt disease type 1 (STGD1) and Geographic Atrophy (GA) in advanced dry age-related macular degeneration (AMD), in addition to specific metabolic diseases. Belite's lead candidate, Tinlarebant, an oral therapy intended to reduce the accumulation of toxins in the eye, is currently being evaluated in a Phase 3 study (DRAGON) and a Phase 2/3 study (DRAGON II) in adolescent STGD1 subjects and a Phase 3 study (PHOENIX) in subjects with GA. For more information, follow us on X, Instagram, LinkedIn, and Facebook or visit us at Media and Investor Relations Contact:Jennifer Wu ir@ Julie Fallonbelite@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
